Market Size of France Aesthetic Medicine Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Market Size (2024) | USD 506.86 Million |
Market Size (2029) | USD 841.08 Million |
CAGR (2024 - 2029) | 10.66 % |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
France Aesthetic Medicine Market Analysis
The France Aesthetic Medicine Market size is estimated at USD 506.86 million in 2024, and is expected to reach USD 841.08 million by 2029, growing at a CAGR of 10.66% during the forecast period (2024-2029).
- Due to the high infectivity of the SARS-CoV-2 virus and lockdown regulations by the government, the COVID-19 pandemic led to the cancellation or postponement of cosmetic treatment treatments, which had an effect on the market for aesthetic medicine in France.
- For instance, according to an article published by the American Society of Plastic Surgeons (ASPS) in February 2021, owing to the strict lockdown imposed in the country, the COVID-19 pandemic significantly changed how plastic surgeons practiced throughout the world, including France. Disruptions in the supply chain posed a significant challenge as the demand decreased due to lower customer purchasing power and willingness to buy.
- According to the French Beauty Federation (FEBEA), the French cosmetic industry saw a 10% decline in revenue during the first half of 2020. The consumers' focus shifted from beauty products to hygiene, with hygiene sales increasing by 50% while beauty product sales decreased by 25%. Cosmetic exports in France fell by 14%, while investments decreased by 12%, which are lower than the national averages of 18% and 16%, respectively. Hence, COVID-19 is expected to impact the studied market significantly.
- The aesthetic medicine market in France is expected to grow during the forecast period owing to increasing awareness about cosmetic procedures and the adoption of non- and minimally-invasive aesthetic procedures.
- For instance, according to the 2020 report of the International Society of Aesthetic Plastic Surgery (ISAPS), France was one of the top fifteen countries in the world with the highest number of plastic surgeons in the country performing various cosmetic procedures in the country. Additionally, France is becoming a popular destination for cosmetic surgery, which is anticipated to benefit the aesthetic medicine market.
- For instance, according to an article published in September 2021 titled "What are the Most Performed Cosmetic Surgery Operations in France?" France is one of the major destinations where most buttock enlargement procedures are performed. Also, per the same source, in France, each year, 479 cosmetic surgery procedures are performed for 100,000 people compared to other countries (166 interventions in Japan, 254 in the United Kingdom, and 69 in India). Thus, an increase in cosmetic procedures in France is expected to drive the market in the forecast period.
- However, stringent safety regulations for aesthetic procedures and related adverse effects are expected to restrain France's aesthetic medicine market growth during the forecast period.
France Aesthetic Medicine Industry Segmentation
Aesthetic medicine is defined as the specialties that focus on enhancing cosmetic appearance through the treatment of aging, infectious, or diseased skin conditions.
The France aesthetic medicine market is segmented by product (botulinum toxin, dermal filler (absorbable dermal filler and non-absorbable dermal filler), chemical peel, microdermabrasion, and other products) and end-user (aesthetic clinics, hospitals, and other end users). The market report also covers the estimated market sizes and trends for France. The report offers the value (in USD million) for the above segments.
By Product | ||||
Botulinum Toxin | ||||
| ||||
Chemical Peel | ||||
Microdermabrasion | ||||
Other Products |
By End User | |
Aesthetic Clinics | |
Hospitals | |
Other End Users |
France Aesthetic Medicine Market Size Summary
The aesthetic medicine market in France is poised for significant growth over the forecast period, driven by increasing awareness and adoption of cosmetic procedures. Despite the challenges posed by the COVID-19 pandemic, which led to a temporary decline in the market due to postponed treatments and shifts in consumer spending, the sector is expected to recover and expand. The country's status as a leading destination for cosmetic surgery, coupled with a high number of plastic surgeons, underscores the robust demand for aesthetic procedures. The market is further bolstered by the popularity of non- and minimally-invasive treatments, such as dermal fillers, which are favored for their versatility and effectiveness in enhancing facial aesthetics. Technological advancements and the introduction of new products are also anticipated to contribute to market growth.
The market landscape is characterized by a mix of global and regional players, with companies like AbbVie Inc. (Allergan Plc), Bioxis Pharmaceuticals, and Johnson & Johnson holding significant shares. The competitive environment is marked by ongoing innovations and regulatory approvals, such as the European Union's endorsement of new botulinum toxin products for wrinkle treatment. The rise in plastic surgeries and increased healthcare expenditure in France are expected to further drive the market. However, the growth trajectory may be tempered by stringent safety regulations and potential adverse effects associated with aesthetic procedures. Overall, the French aesthetic medicine market is set to experience healthy expansion, supported by a combination of consumer demand, technological advancements, and a favorable regulatory environment.
France Aesthetic Medicine Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Growing Awareness and Adoption of Non- and Minimally-Invasive Aesthetic Procedures
-
1.2.2 Availability of Technologically Advanced & User-friendly Products
-
-
1.3 Market Restraints
-
1.3.1 Stringent Safety Regulations for Aesthetic Procedures
-
1.3.2 Risk of Side Effects
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - in USD Millions)
-
2.1 By Product
-
2.1.1 Botulinum Toxin
-
2.1.2 Dermal Filler
-
2.1.2.1 Absorbable Dermal Filler
-
2.1.2.2 Non-absorbable Dermal Filler
-
-
2.1.3 Chemical Peel
-
2.1.4 Microdermabrasion
-
2.1.5 Other Products
-
-
2.2 By End User
-
2.2.1 Aesthetic Clinics
-
2.2.2 Hospitals
-
2.2.3 Other End Users
-
-
France Aesthetic Medicine Market Size FAQs
How big is the France Aesthetic Medicine Market?
The France Aesthetic Medicine Market size is expected to reach USD 506.86 million in 2024 and grow at a CAGR of 10.66% to reach USD 841.08 million by 2029.
What is the current France Aesthetic Medicine Market size?
In 2024, the France Aesthetic Medicine Market size is expected to reach USD 506.86 million.